Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q1 2021 · 10-Q
Revenue$24.46M$24.46M+13.5% vs Q1 2020 Net Income$661.00K$661.00KN/M vs Q1 2020 EPS Diluted$0.03$0.03N/M vs Q1 2020 Gross Profit$14,576,000+15.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flow$2,651,000+375.9% Free Cash Flowderived$2,513,000+8,875.0% Margins · derivedGross margin59.6%+0.8 pt vs Q1 2020
Operating margin3.6%+3.4 pt vs Q1 2020
Net margin2.7%+4.6 pt vs Q1 2020
ended Mar 31, 2021 · filed May 10, 2021 · 40 d after period end